US2015010651A1PendingUtilityA1
Compositions and methods for the treatment of wounds
Est. expiryMar 25, 2029(~2.6 yrs left)· nominal 20-yr term from priority
Inventors:Keshav Malshe
A61L 2300/204A61K 33/06A61L 2300/45A61K 31/519A61P 17/02A61K 31/341A61K 31/4166A61K 31/415A61L 2300/428A61P 17/00A61K 31/355A61L 26/0066A61K 31/375
33
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to a wound composition comprising an effective amount of phenyloin and an effective amount of vitamin C. The present invention is further directed to a method of treating a wound in a patient comprising administering an effective amount of phenyloin and an effective amount of vitamin C to the wound.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A wound composition comprising an effective amount of phenyloin, an effective amount of vitamin C, and a conjunctive compound, wherein said conjunctive compound is vitamin E, follic acid, and/or magnesium.
18 . The wound composition of claim 17 , wherein said composition comprises vitamin E, follic acid, and magnesium.
19 . The wound composition of claim 17 , wherein the wound composition comprises a powder.
20 . The wound composition of claim 17 , wherein the wound composition comprises at least one of an ointment, lotion, cream, and/or gel.
21 . A wound composition comprising an effective amount of phenyloin, vitamin C, vitamin E, follic acid, and/or magnesium in combination with honey.
22 . A pharmaceutical composition consisting essentially of an effective amount of phenyloin and an effective amount of vitamin C and at least one pharmaceutical acceptable excipient.Join the waitlist — get patent alerts
Track US2015010651A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.